DE354848T1 - Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l-lysin. - Google Patents

Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l-lysin.

Info

Publication number
DE354848T1
DE354848T1 DE198989402257T DE89402257T DE354848T1 DE 354848 T1 DE354848 T1 DE 354848T1 DE 198989402257 T DE198989402257 T DE 198989402257T DE 89402257 T DE89402257 T DE 89402257T DE 354848 T1 DE354848 T1 DE 354848T1
Authority
DE
Germany
Prior art keywords
carnitine
lysine
pharmaceutical
compositions containing
dietetic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE198989402257T
Other languages
English (en)
Inventor
Henri F-75013 Paris Fr Laborit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRE ROGER BELLON NEUILLY SUR SEINE FR
Original Assignee
LABORATOIRE ROGER BELLON NEUILLY SUR SEINE FR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LABORATOIRE ROGER BELLON NEUILLY SUR SEINE FR filed Critical LABORATOIRE ROGER BELLON NEUILLY SUR SEINE FR
Publication of DE354848T1 publication Critical patent/DE354848T1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE198989402257T 1988-08-12 1989-08-10 Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l-lysin. Pending DE354848T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8810886A FR2635264B1 (fr) 1988-08-12 1988-08-12 Compositions pharmaceutiques et/ou dietetiques contenant de la l-carnitine et de la l-lysine

Publications (1)

Publication Number Publication Date
DE354848T1 true DE354848T1 (de) 1992-05-21

Family

ID=9369324

Family Applications (2)

Application Number Title Priority Date Filing Date
DE198989402257T Pending DE354848T1 (de) 1988-08-12 1989-08-10 Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l-lysin.
DE8989402257T Expired - Fee Related DE68903448T2 (de) 1988-08-12 1989-08-10 Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l-lysin.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8989402257T Expired - Fee Related DE68903448T2 (de) 1988-08-12 1989-08-10 Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l-lysin.

Country Status (10)

Country Link
EP (2) EP0428608A1 (de)
JP (1) JP2785989B2 (de)
AT (1) ATE82122T1 (de)
CA (1) CA1341260C (de)
DE (2) DE354848T1 (de)
ES (1) ES2043062T3 (de)
FR (1) FR2635264B1 (de)
GR (2) GR900300149T1 (de)
PT (1) PT91430B (de)
WO (1) WO1990001316A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660557B1 (fr) * 1990-04-09 1994-05-27 Endobio Groupe Etu Rech Risqu Compositions pharmaceutiques et/ou dietetiques contenant de la carnitine, de la lysine et de la methionine avec ou sans acide pantothenique.
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
IT1306147B1 (it) 1999-05-28 2001-05-30 Biosalts Srl Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
IT1306186B1 (it) * 1999-09-03 2001-05-30 Biosalts Srl Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale
IT1317042B1 (it) * 2000-06-14 2003-05-26 Biosalts Srl Fumarati doppi di una carnitina e creatina, e integratori alimentari,dietetici e farmaci che li contengono.
JP6766044B2 (ja) * 2015-07-01 2020-10-07 株式会社明治 継粉形成抑制剤
AU2018258250A1 (en) * 2017-04-25 2019-12-12 Almeda Labs Llc Amino acid formulations for pancreatic viability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4465M (de) * 1965-06-28 1966-09-26
FR2119882A1 (en) * 1970-12-31 1972-08-11 Prugnaud Robert Calcium hypophosphite-ascorbate/carnitine compsn - used as appetite stimulant
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion

Also Published As

Publication number Publication date
PT91430B (pt) 1995-05-31
ES2043062T3 (es) 1993-12-16
GR900300149T1 (en) 1991-09-27
DE68903448T2 (de) 1993-03-18
GR3006598T3 (de) 1993-06-30
JP2785989B2 (ja) 1998-08-13
EP0354848A1 (de) 1990-02-14
PT91430A (pt) 1990-03-08
EP0354848B1 (de) 1992-11-11
EP0428608A1 (de) 1991-05-29
JPH04500073A (ja) 1992-01-09
FR2635264A1 (fr) 1990-02-16
DE68903448D1 (de) 1992-12-17
CA1341260C (fr) 2001-06-19
WO1990001316A1 (fr) 1990-02-22
ATE82122T1 (de) 1992-11-15
FR2635264B1 (fr) 1992-02-28

Similar Documents

Publication Publication Date Title
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE69629273D1 (de) Zusammensetzungen enthaltend Propionyl-L-Carnitine und Hydroxyzitronensäure oder Pantothensäure
KR840003414A (ko) 3-히드록시부탄산 또는 이 산으로부터 유도된 염을 함유하는 약학적 조성물과, 의약품으로 사용할 수 있는 3-히드록시부탄산으로부터 유도된 화합물
PT614616E (pt) Composicao para o tratamento de pacientes com doenca hepatica
DK341187A (da) Virucidt middel med bredspekret virkning
ATE43242T1 (de) Pharmazeutische oder diaetetische zusammensetzung mit hoher antithrombotischer und antiarteriosklerotischer wirkung.
DE69114498T2 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
SE8005890L (sv) Salter av (+)-katekin, deras framstellning och anvendning, och kompositioner innehallande dessa salter
DE69302883T2 (de) L-Carnitin- und Alkanoyl-L-Carnitin-Ester mit Glykolsäure oder ihre Ester und diese enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
PT1216041E (pt) Dieta com elevado teor de lipidos
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
ATE11014T1 (de) Pharmazeutische und diaetetische zusammensetzung zur erhoehung der serie-l-pg-produktion.
DE68903448T2 (de) Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l-lysin.
PT95212A (pt) Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide
FI934082A0 (fi) Kitosanbaserade naerings- och laekemedelskompositioner foer idisslare
ATE34662T1 (de) Derivate der benzoesaeure, herstellungsverfahren und anwendung in desinfizierenden und konservierenden arzneimitteln.
SE8902607D0 (sv) Oxaza heterocycles and pharmaceutical compositions containing same
DE3874142T2 (de) Pharmazeutische zusammensetzung mit antikrebswirkung und methode fuer die behandlung von krebs.
ES2126015T3 (es) Uso de etofibrato y composiciones farmaceuticas que contienen etofibrato para el tratamiento de la angiopatia y la retinopatia diabeticas.
KR900015616A (ko) 배나무 점무늬병 치료제.
GT198500020A (es) 1,4-dihidropiridinlactonas 1-alquil-sustituidas, procedimiento para su obtencion y su empleo en medicamentos.
MX9204423A (es) Medicamento que contiene antagonistas de calcio y procedimiento para su fabricacion.
MacLaren An in vitro comparison of stress resistance of five bonding products under a moisture stress environment
JPS6490104A (en) Controller for violet root rot
KR830005856A (ko) 소염, 해열 및 진통제 조성물